CSF3 and Cognitive impairment: In an earlier study, we reported that G-CSF therapy alleviates the decrease in pCREBSer-133 and PSD-95 with NMDAR subunits within the CA1 region of the hippocampus after perinatal hypoxia and that G-CSF therapy provides beneficial effects for long-term cognitive deficits [53].